High-throughput ectopic expression screen for tamoxifen resistance identifies an atypical kinase that blocks autophagy
- 13 January 2011
- journal article
- research article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences of the United States of America
- Vol. 108 (5), 2058-2063
- https://doi.org/10.1073/pnas.1018157108
Abstract
Resistance to tamoxifen in breast cancer patients is a serious therapeutic problem and major efforts are underway to understand underlying mechanisms. Resistance can be either intrinsic or acquired. We derived a series of subcloned MCF7 cell lines that were either highly sensitive or naturally resistant to tamoxifen and studied the factors that lead to drug resistance. Gene-expression studies revealed a signature of 67 genes that differentially respond to tamoxifen in sensitive vs. resistant subclones, which also predicts disease-free survival in tamoxifen-treated patients. High-throughput cell-based screens, in which >500 human kinases were independently ectopically expressed, identified 31 kinases that conferred drug resistance on sensitive cells. One of these, HSPB8, was also in the expression signature and, by itself, predicted poor clinical outcome in one cohort of patients. Further studies revealed that HSPB8 protected MCF7 cells from tamoxifen and blocked autophagy. Moreover, silencing HSBP8 induced autophagy and caused cell death. Tamoxifen itself induced autophagy in sensitive cells but not in resistant ones, and tamoxifen-resistant cells were sensitive to the induction of autophagy by other drugs. These results may point to an important role for autophagy in the sensitivity to tamoxifen.This publication has 40 references indexed in Scilit:
- The significance of autophagy in cancerMolecular Carcinogenesis, 2005
- Overview of tyrosine kinase inhibitors in clinical breast cancerEndocrine-Related Cancer, 2005
- Building a human kinase gene repository: Bioinformatics, molecular cloning, and functional validationProceedings of the National Academy of Sciences of the United States of America, 2005
- Synergistic Augmentation of Rapamycin-Induced Autophagy in Malignant Glioma Cells by Phosphatidylinositol 3-Kinase/Protein Kinase B InhibitorsCancer Research, 2005
- Molecular Classification of Tamoxifen-Resistant Breast Carcinomas by Gene Expression ProfilingJournal of Clinical Oncology, 2005
- A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast CancerThe New England Journal of Medicine, 2004
- Mechanisms of tamoxifen resistanceEndocrine-Related Cancer, 2004
- MEK inhibitors: The chemistry and biological activity of U0126, its analogs, and cyclization productsBioorganic & Medicinal Chemistry Letters, 1998
- Subpopulations of MCF7 cells separated by Percoll gradient centrifugation: a model to analyze the heterogeneity of human breast cancer.Proceedings of the National Academy of Sciences of the United States of America, 1987
- Steroid receptor-mediated cytotoxicity of an antiestrogen and an antiprogestin in breast cancer cells.1987